MYCO-B ONE DOSE
  • UPDATE: NEW FEEDLOT STUDY
    • Study Detailer
    • Study Overview
    • Study Paper
  • Home
  • About M. bovis
    • M. bovis global reach
    • About Mycoplasma bovis
    • About M. bovis con'td
  • Product Insert
  • Studies
    • Why MYCO-B ONE DOSE?
    • Respiratory Studies
    • Arthritis Studies
    • 2018 Feedlot Study
    • NEW: 2019 Feedlot Study
  • Where to Buy
  • Contact Us

Host Animal Immunogenicity Studies - Respiratory

Picture

Lung Lesions

Lung lesion scores in both efficacy
studies were significantly reduced
after  vaccination, especially in ​Trial 2.
Trial 1:  p<0.05 is significant.
Trial 2:  p<0.01 is VERY significant.


Picture

M. bovis isolation from lungs

In both efficacy studies, M. bovis was significantly reduced in the vaccinate groups, compared to control group (p<0.05).
Picture

Antibody Response 

MYCO-B  ONE DOSE™ vaccination               induced higher IgG titers in calves.
More studies
Picture
© COPYRIGHT 2016. American Animal Health, Inc.;  
​Grand Prairie, TX 75052 USA; ​ ALL RIGHTS RESERVED.
  • UPDATE: NEW FEEDLOT STUDY
    • Study Detailer
    • Study Overview
    • Study Paper
  • Home
  • About M. bovis
    • M. bovis global reach
    • About Mycoplasma bovis
    • About M. bovis con'td
  • Product Insert
  • Studies
    • Why MYCO-B ONE DOSE?
    • Respiratory Studies
    • Arthritis Studies
    • 2018 Feedlot Study
    • NEW: 2019 Feedlot Study
  • Where to Buy
  • Contact Us